329 related articles for article (PubMed ID: 10092207)
1. Physiological signals and oncogenesis mediated through Crk family adapter proteins.
Feller SM; Posern G; Voss J; Kardinal C; Sakkab D; Zheng J; Knudsen BS
J Cell Physiol; 1998 Dec; 177(4):535-52. PubMed ID: 10092207
[TBL] [Abstract][Full Text] [Related]
2. Crk family adaptors-signalling complex formation and biological roles.
Feller SM
Oncogene; 2001 Oct; 20(44):6348-71. PubMed ID: 11607838
[TBL] [Abstract][Full Text] [Related]
3. The germinal center kinase (GCK)-related protein kinases HPK1 and KHS are candidates for highly selective signal transducers of Crk family adapter proteins.
Oehrl W; Kardinal C; Ruf S; Adermann K; Groffen J; Feng GS; Blenis J; Tan TH; Feller SM
Oncogene; 1998 Oct; 17(15):1893-901. PubMed ID: 9788432
[TBL] [Abstract][Full Text] [Related]
4. p130CAS forms a signaling complex with the adapter protein CRKL in hematopoietic cells transformed by the BCR/ABL oncogene.
Salgia R; Pisick E; Sattler M; Li JL; Uemura N; Wong WK; Burky SA; Hirai H; Chen LB; Griffin JD
J Biol Chem; 1996 Oct; 271(41):25198-203. PubMed ID: 8810278
[TBL] [Abstract][Full Text] [Related]
5. BCR/ABL P190 transgenic mice develop leukemia in the absence of Crkl.
Hemmeryckx B; Reichert A; Watanabe M; Kaartinen V; de Jong R; Pattengale PK; Groffen J; Heisterkamp N
Oncogene; 2002 May; 21(20):3225-31. PubMed ID: 12082638
[TBL] [Abstract][Full Text] [Related]
6. Development of highly selective SH3 binding peptides for Crk and CRKL which disrupt Crk-complexes with DOCK180, SoS and C3G.
Posern G; Zheng J; Knudsen BS; Kardinal C; Müller KB; Voss J; Shishido T; Cowburn D; Cheng G; Wang B; Kruh GD; Burrell SK; Jacobson CA; Lenz DM; Zamborelli TJ; Adermann K; Hanafusa H; Feller SM
Oncogene; 1998 Apr; 16(15):1903-12. PubMed ID: 9591773
[TBL] [Abstract][Full Text] [Related]
7. Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr-Abl signal transduction and oncogenesis.
Wilson MB; Schreiner SJ; Choi HJ; Kamens J; Smithgall TE
Oncogene; 2002 Nov; 21(53):8075-88. PubMed ID: 12444544
[TBL] [Abstract][Full Text] [Related]
8. Crk-associated substrate p130(Cas) interacts with nephrocystin and both proteins localize to cell-cell contacts of polarized epithelial cells.
Donaldson JC; Dempsey PJ; Reddy S; Bouton AH; Coffey RJ; Hanks SK
Exp Cell Res; 2000 Apr; 256(1):168-78. PubMed ID: 10739664
[TBL] [Abstract][Full Text] [Related]
9. The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3' kinase pathway.
Sattler M; Salgia R; Okuda K; Uemura N; Durstin MA; Pisick E; Xu G; Li JL; Prasad KV; Griffin JD
Oncogene; 1996 Feb; 12(4):839-46. PubMed ID: 8632906
[TBL] [Abstract][Full Text] [Related]
10. The BCR/ABL oncogene alters interaction of the adapter proteins CRKL and CRK with cellular proteins.
Uemura N; Salgia R; Li JL; Pisick E; Sattler M; Griffin JD
Leukemia; 1997 Mar; 11(3):376-85. PubMed ID: 9067577
[TBL] [Abstract][Full Text] [Related]
11. Transformation suppressor activity of C3G is independent of its CDC25-homology domain.
Guerrero C; Fernandez-Medarde A; Rojas JM; Font de Mora J; Esteban LM; Santos E
Oncogene; 1998 Feb; 16(5):613-24. PubMed ID: 9482107
[TBL] [Abstract][Full Text] [Related]
12. Crk adapter proteins promote an epithelial-mesenchymal-like transition and are required for HGF-mediated cell spreading and breakdown of epithelial adherens junctions.
Lamorte L; Royal I; Naujokas M; Park M
Mol Biol Cell; 2002 May; 13(5):1449-61. PubMed ID: 12006644
[TBL] [Abstract][Full Text] [Related]
13. The product of the cellular crk gene consists primarily of SH2 and SH3 regions.
Reichman CT; Mayer BJ; Keshav S; Hanafusa H
Cell Growth Differ; 1992 Jul; 3(7):451-60. PubMed ID: 1329926
[TBL] [Abstract][Full Text] [Related]
14. C3G is tyrosine-phosphorylated after integrin-mediated cell adhesion in normal but not in Bcr/Abl expressing cells.
de Jong R; van Wijk A; Heisterkamp N; Groffen J
Oncogene; 1998 Nov; 17(21):2805-10. PubMed ID: 9840945
[TBL] [Abstract][Full Text] [Related]
15. A role for Ras in v-Crk transformation.
Greulich H; Hanafusa H
Cell Growth Differ; 1996 Nov; 7(11):1443-51. PubMed ID: 8930393
[TBL] [Abstract][Full Text] [Related]
16. The Nck SH2/SH3 adaptor protein: a regulator of multiple intracellular signal transduction events.
McCarty JH
Bioessays; 1998 Nov; 20(11):913-21. PubMed ID: 9872057
[TBL] [Abstract][Full Text] [Related]
17. Cellular proteins binding to the first Src homology 3 (SH3) domain of the proto-oncogene product c-Crk indicate Crk-specific signaling pathways.
Feller SM; Knudsen B; Hanafusa H
Oncogene; 1995 Apr; 10(8):1465-73. PubMed ID: 7731701
[TBL] [Abstract][Full Text] [Related]
18. Tyrosine phosphorylation of murine Crkl.
de Jong R; Haataja L; Voncken JW; Heisterkamp N; Groffen J
Oncogene; 1995 Oct; 11(8):1469-74. PubMed ID: 7478571
[TBL] [Abstract][Full Text] [Related]
19. Met-induced JNK activation is mediated by the adapter protein Crk and correlates with the Gab1 - Crk signaling complex formation.
Garcia-Guzman M; Dolfi F; Zeh K; Vuori K
Oncogene; 1999 Dec; 18(54):7775-86. PubMed ID: 10618718
[TBL] [Abstract][Full Text] [Related]
20. Src-dependent association of Cas and p85 phosphatidylinositol 3'-kinase in v-crk-transformed cells.
Riggins RB; DeBerry RM; Toosarvandani MD; Bouton AH
Mol Cancer Res; 2003 Apr; 1(6):428-37. PubMed ID: 12692262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
